INEGY 10 MG80 MG TABLETS

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

EZETIMIBE; SIMVASTATIN

Dostupné z:

MERCK SHARP & DOHME ISRAEL LTD

ATC kód:

C10AA01

Forma lieku:

TABLETS

Zloženie:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Spôsob podávania:

PER OS

Typ predpisu:

Required

Výrobca:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapeutické skupiny:

SIMVASTATIN

Terapeutické oblasti:

SIMVASTATIN

Terapeutické indikácie:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Dátum Autorizácia:

2012-04-30